Evidence map›Paper›PMID 40430703›Full record

ArticlePolymers2025

Applicability Domain of the Sens-Is In Vitro Assay for Testing the Skin Sensitization Potential of Rheology-Modifying Polymers.

Isabelle Hochar, Mickaël Puginier, Hervé Groux, Jérôme Guilbot, Françoise Cottrez, Alicia Roso

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Isabelle HocharSeppic Regulatory, 50 Boulevard National, 92257 La Garenne Colombes, France.
Mickaël PuginierSeppic Regulatory, 50 Boulevard National, 92257 La Garenne Colombes, France.
Hervé GrouxIMMUNOSEARCH, Les Cyclades, Chemin de Camperousse, 06130 Grasse, France.
Jérôme GuilbotSeppic Research & Innovation, 127 Chemin de la Poudrerie, 81105 Castres, France.
Françoise CottrezIMMUNOSEARCH, Les Cyclades, Chemin de Camperousse, 06130 Grasse, France.
Alicia RosoSeppic Research & Innovation, 127 Chemin de la Poudrerie, 81105 Castres, France.ORCID 0000-0002-9894-2623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Assessing the propensity of ingredients to induce skin sensitization through in vitro testing is crucial for worker and consumer safety. This is particularly important for novel and high-performance ingredients with complex structures, such as rheology-modifying polymers, which are extensively used in cosmetics, pharmaceuticals, and detergents. The Sens-Is assay has proven effective in distinguishing skin sensitizers from non-sensitizers for difficult-to-test ingredients when integrated into a multi-method in vitro approach. Therefore, the primary goal of this research was to explore whether the Sens-Is in vitro assay is suitable to evaluate rheology-modifying polymers. Fifteen structurally diverse rheology-modifying polymers, including natural polymers obtained by extraction, chemical synthesis, or biotechnology, spanning varying physical forms and concentrations, were evaluated. The results showed that most polymers were non-sensitizing, consistent with available in vivo data. Although polymer macromolecules generally exhibit limited skin sensitization potential due to their surface confinement, the Sens-Is assay permitted the detection of weak signals from secondary components or possible byproducts in specific cases. This work confirms Sens-Is as a useful tool in an overall approach to assessing the skin sensitization liability of polymers under development, but careful solvent selection is crucial to ensure accurate results and prevent potential overexposure due to polymer retention on the epidermal surface.

Indexed as

cosmeticsplant-based polymerpolysaccharidesrheology-modifying polymersSens-Is assayskin sensitizationsynthetic polymers

Identifiers

PMID40430703
PMCPMC12115193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.